Dimensional Fund Advisors LP Aveo Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$6.61 - $8.72 $11,898 - $15,696	-1,800 Reduced 7.19%	23,227 $191,000
Q1 2022 May 13, 2022	BUY	$3.15 - $6.01 $630 - $1,202	200 Added 0.81%	25,027 $140,000
Q4 2021 Feb 09, 2022	BUY	$4.69 - $7.4 $5,365 - $8,465	1,144 Added 4.83%	24,827 $116,000
Q3 2021 Nov 12, 2021	SELL	$5.12 - $6.89 $23,869 - $32,121	-4,662 Reduced 16.45%	23,683 $146,000
Q1 2021 May 14, 2021	BUY	$5.97 - $15.28 $23,784 - $60,875	3,984 Added 16.35%	28,345 $207,000
Q4 2020 Feb 25, 2021	BUY	$5.08 - $6.68 $123,753 - $162,731	24,361 New	24,361 $141,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.